Cross Country Healthcare Stock Current Valuation
CCRN Stock | USD 18.72 0.29 1.57% |
Valuation analysis of Cross Country Healthcare helps investors to measure Cross Country's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 29th of March 2024, Enterprise Value Multiple is likely to drop to 5.50. Fundamental drivers impacting Cross Country's valuation include:
Price Book 1.3717 | Enterprise Value 637.5 M | Enterprise Value Ebitda 4.9294 | Price Sales 0.3219 | Forward PE 19.685 |
Undervalued
Today
Please note that Cross Country's price fluctuation is not too volatile at this time. Calculation of the real value of Cross Country Healthcare is based on 3 months time horizon. Increasing Cross Country's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cross Country Healthcare is useful when determining the fair value of the Cross stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cross Country. Since Cross Country is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cross Stock. However, Cross Country's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 18.72 | Real 23.64 | Target 27.8 | Hype 18.78 |
The real value of Cross Stock, also known as its intrinsic value, is the underlying worth of Cross Country Healthcare Company, which is reflected in its stock price. It is based on Cross Country's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Cross Country's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cross Country's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cross Country Healthcare helps investors to forecast how Cross stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cross Country more accurately as focusing exclusively on Cross Country's fundamentals will not take into account other important factors: Cross Current Valuation Analysis
Cross Country's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
More About Current Valuation | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 375.0M | 627.7M | 432.1M | 216.1M | Total Revenue | 1.7B | 2.8B | 2.0B | 2.1B |
Enterprise Value | = | Market Cap + Debt | - | Cash |
Current Cross Country Current Valuation | 637.54 M |
Most of Cross Country's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cross Country Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cross Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Cross Country is extremely important. It helps to project a fair market value of Cross Stock properly, considering its historical fundamentals such as Current Valuation. Since Cross Country's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cross Country's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cross Country's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Cross Country Healthcare has a Current Valuation of 637.54 M. This is 95.56% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 96.16% higher than that of the company.
Cross Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cross Country's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cross Country could also be used in its relative valuation, which is a method of valuing Cross Country by comparing valuation metrics of similar companies.Cross Country is currently under evaluation in current valuation category among related companies.
Cross Fundamentals
Return On Equity | 0.16 | ||||
Return On Asset | 0.09 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.03 % | ||||
Current Valuation | 637.54 M | ||||
Shares Outstanding | 34.73 M | ||||
Shares Owned By Insiders | 5.55 % | ||||
Shares Owned By Institutions | 94.45 % | ||||
Number Of Shares Shorted | 5.27 M | ||||
Price To Earning | 5.59 X | ||||
Price To Book | 1.37 X | ||||
Price To Sales | 0.32 X | ||||
Revenue | 2.02 B | ||||
Gross Profit | 627.69 M | ||||
EBITDA | 135.46 M | ||||
Net Income | 72.63 M | ||||
Cash And Equivalents | 279 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 5.27 M | ||||
Debt To Equity | 0.53 % | ||||
Current Ratio | 2.67 X | ||||
Book Value Per Share | 13.77 X | ||||
Cash Flow From Operations | 252.87 M | ||||
Short Ratio | 8.53 X | ||||
Earnings Per Share | 2.05 X | ||||
Price To Earnings To Growth | 1.97 X | ||||
Target Price | 19.17 | ||||
Number Of Employees | 13.13 K | ||||
Beta | 0.74 | ||||
Market Capitalization | 650.07 M | ||||
Total Asset | 679.32 M | ||||
Retained Earnings | 238.36 M | ||||
Working Capital | 266.57 M | ||||
Current Asset | 158.75 M | ||||
Current Liabilities | 86.05 M | ||||
Z Score | 78.64 | ||||
Net Asset | 679.32 M |
About Cross Country Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cross Country Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cross Country using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cross Country Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company was founded in 1986 and is headquartered in Boca Raton, Florida. Cross Ctry operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 2250 people.
Pair Trading with Cross Country
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.Moving against Cross Stock
0.93 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.89 | BSX | Boston Scientific Corp Financial Report 24th of April 2024 | PairCorr |
0.77 | PNTG | Pennant Group Financial Report 2nd of May 2024 | PairCorr |
0.71 | MDWD | Mediwound Downward Rally | PairCorr |
0.61 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.
The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cross Country Piotroski F Score and Cross Country Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Cross Stock analysis
When running Cross Country's price analysis, check to measure Cross Country's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cross Country is operating at the current time. Most of Cross Country's value examination focuses on studying past and present price action to predict the probability of Cross Country's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cross Country's price. Additionally, you may evaluate how the addition of Cross Country to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Cross Country's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.75) | Earnings Share 2.05 | Revenue Per Share 57.447 | Quarterly Revenue Growth (0.34) | Return On Assets 0.09 |
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.